PATENT CLAIM ANALYSIS

Application Number: 16225469
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-05
Patent Classification: ["435", "007920"]

Abstract:
Methods and reagents are disclosed for minimizing a false result in an assay measurement for determining a concentration of an analyte in a sample suspected of containing the analyte. The method comprises pretreating both an antibody and a sample to be subjected to a non-agglutination immunoassay. In the method the antibody and the sample are combined with a pretreatment agent selected from the group consisting of hydroxyphenyl-substituted C1-C5 carboxylic acids and metallic salts thereof and halogen-substituted C1-C5 carboxylic acids and metallic salts thereof in an amount effective to enhance the accuracy of the non-agglutination immunoassay.

Claim (Index 20):
The method according to  claim 12  wherein the combination further comprises structural analog of the immunosuppressant drug and at least one of the antibody for the immunosuppressant drug or the analog comprises a label.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 98.0
- Lexical Diversity: 1.78182
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13282957', '13026756', '13196831', '12491394', '12845265']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6424676325305593
- 35 USC 102 Novelty (BERT): 0.5013506134326063
- Combined Prediction Score: 0.628355930620764
- Mean Citation Score: 239.56573000000003
- Max Citation Score: 242.02159
- Similarity Product: 160.61313609134675

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test